RYAN SPECIALTY HOLDINGS, INC. (RYAN): Results of Operations and Financial Condition
RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ryan-20260630xex991.htm EX-99.1 RYAN-2026.06.30-EX 99.1 1 RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS - Total Revenue grew 7.2% year-over-year to $916.6 million - - Organic Revenue Growth Rate* of 6.7% year-over-year - - Net Income of $108.4 million , or $0.33 pe
How this was made
The 30-second read
Why it matters
Traders can update near-term expectations for specialty insurance distribution performance using the reported revenue growth, adjusted profitability, and capital return actions (repurchases and dividends).
Market read
This is a primary earnings disclosure with multiple quantified KPIs and a capital return update, which can drive same-day positioning and revisions to forward estimates.
What to watch
Adjusted EBITDAC margin declined (36.1% to 35.7%) and operating income fell 5.6% YoY, which could matter more than revenue growth for valuation and forward expectations.
Background
The company filed an SEC 8-K with Item 2.02 and an attached exhibit (EX-99.1) reporting second quarter 2026 financial results ended June 30, 2026.
Ticker impact
Ryan Specialty reported Q2 2026 results, with revenue up 7.2% YoY to $916.6M and adjusted diluted EPS up 12.1% to $0.74.
Near-term bias likely depends on how investors weigh adjusted EPS strength versus GAAP net income decline and margin compression.
The filing provides multiple hard datapoints: revenue and adjusted metrics rose, while GAAP net income and net income margin declined, plus adjusted EBITDAC margin eased from 36.1% to 35.7%.
Market effects
Specialty insurance distributors may see read-through demand for wholesale brokerage and E&S flows given Ryan’s organic growth and commentary on technology/AI investments.
Limited; company-specific results with no stated regional regulatory or macro shock.
Limited; no international deal, regulatory action, or catastrophe exposure disclosed in the excerpt.
Counterpoint
Investors may discount adjusted metrics if GAAP net income and net income margin are deteriorating, implying earnings quality or cost pressures not fully captured by non-GAAP measures.
Key entities
- issuerRyan Specialty Holdings, Inc.
Reported Q2 2026 revenue growth, adjusted earnings improvement, GAAP net income decline, and capital return via buybacks and dividends.
- executivePatrick G. Ryan
Founder and Executive Chairman; cited organic growth and capital return, plus technology/AI investments.
- executiveTimothy W. Turner
CEO; emphasized platform positioning and investments in technology, AI, and data.
